Quantcast

Latest Astellas Pharma US Inc. Stories

2010-11-02 07:00:00

CHICAGO and DEERFIELD, Ill., Nov. 2, 2010 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), a research-based pharmaceutical company based in Deerfield, Ill., is pleased to donate 150 used laptops to Midtown Educational Foundation, a nonprofit academic enrichment organization that serves over 1,000 students and parents in need each year through its Chicago-based Metro Achievement Center for girls and Midtown Center for boys. "The Midtown Educational Foundation is thrilled to partner...

2010-10-28 08:01:00

CHICAGO and DEERFIELD, Ill., Oct. 28 /PRNewswire/ -- A new national survey released today shows large percentages of science teachers and parents strongly agree that demonstrating real-life applications in science (87 percent and 72 percent, respectively) can help make science education more interesting for U.S. students. Almost all science teachers (99 percent) and nine in ten parents (90 percent) feel that science education is important, if not very important for a child's future, but...

2010-09-25 06:00:00

PHILADELPHIA, Sept. 25 /PRNewswire/ -- Today Astellas Pharma US, Inc. ("Astellas") announced results of a Phase IV study showing Lexiscan® (regadenoson) Injection was comparable to placebo in causing a >15% decrease in forced expiratory volume in one second (FEV1) in subjects with asthma or chronic obstructive pulmonary disease (COPD) who are likely candidates for myocardial perfusion imaging (MPI) studies(1). Results were presented during an oral presentation today at...

2010-09-24 15:08:00

PHILADELPHIA, Sept. 24 /PRNewswire/ -- Today Astellas Pharma US, Inc. ("Astellas") announced the Launch of the Appropriate Use Criteria (AUC) for Cardiac Radionuclide Imaging application (app) for smartphones. The app is designed to give physicians access to published criteria used to assess the need for a patient to have cardiac radionuclide imaging (RNI). The app will be available for free download on the iPhone®, BlackBerry® and Android(TM) platforms....

2010-09-17 08:00:00

DEERFIELD, Ill., Sept. 17 /PRNewswire/ -- Today, approximately 500 employees at Astellas Pharma US, Inc. ("Astellas") are taking a break from their daily routine to pack food at local pantries, paint murals in under-resourced schools, engage kids in healthy living activities and landscape public gardens in the Chicagoland area through a partnership with Chicago Cares. These efforts are part of the first annual "Changing Tomorrow Day," a global volunteer initiative that empowers Astellas...

2010-09-15 08:00:00

DEERFIELD, Ill., Sept. 15 /PRNewswire/ -- Astellas Pharma US, Inc. has announced the winners of the second 2010 Transplant Scholars Awards, which awarded a dozen $5,000 educational scholarships to transplant recipients and living donors from around the country to help them pursue their educational goals and gain even more power to make a real difference in the lives of the people around them. Scholarship winners were chosen from among 283 entries by a panel of judges who evaluated the...

2010-09-15 08:00:00

DEERFIELD, Ill., Sept. 15 /PRNewswire/ -- On January 1, 2011, the Donate Life float will roll through the streets of Pasadena reminding millions of viewers of the Rose Parade® to "Seize the Day" and register as organ donors in an effort to save lives. Aboard the float will be the five winners of the 2011 Astellas Ride of a Lifetime(SM) Contest, whose stories about how transplant changed their lives serve as an inspiration to others. Astellas Pharma US, Inc., is a top-level...

2010-07-02 07:00:00

MORRISTOWN, N.J., July 2 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for Tacrolimus 5 mg capsules, the generic equivalent to Astellas' Prograf® capsules. Watson intends to begin shipping the product immediately. Prograf ® 5 mg had total U.S....

2010-06-07 08:00:00

CHICAGO, June 7 /PRNewswire/ -- If an average day begins as a hectic race to get the kids off to school and get to work on time, imagine starting that day with a migraine. For many of the nation's 30 million migraine sufferers whose lives are often turned upside down by their migraines, relief can't come soon enough. In a new survey released today by the National Headache Foundation (NHF), 3 in 4 migraine sufferers said their current medication doesn't work fast enough to get them back to...

2010-05-16 19:20:00

TOKYO and MELVILLE, N.Y. May 16 /PRNewswire-FirstCall/ -- Astellas Pharma Inc. (TSE: 4503), a global pharmaceutical company, and OSI Pharmaceuticals, Inc. (Nasdaq: OSIP), a biotechnology company primarily focused on the discovery, development and commercialization of molecular targeted therapies addressing medical needs in oncology, diabetes and obesity, today announced that they have entered into a definitive merger agreement under which Astellas will acquire OSI. Under the terms of...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.